Non-Hodgkin Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

By Disease Type (B-cell Lymphomas, T-cell Lymphoma), By Drug Class (Monoclonal Antibodies, Antibody-Drug Conjugates, BTK/BCL-2 Kinase Inhibitors, PI3 Kinase Inhibitors, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), By Region and Competition

Published	Pages	Publisher	Report code
Feb 2024	130	TechSci Research	ASDR-657562

Published: Feb 2024 - Pages : 130 - Publisher : TechSci Research - Report code : ASDR-657562

1. AbbVie Inc
2. Bristol-Myers Squibb Company
3. AstraZeneca plc
4. Johnson & Johnson
5. Novartis AG
6. Seagen
Inc
7. Bayer AG
8. F. Hoffmann-La Roche Ltd
9. Gilead Sciences Inc
10. Merck & Co. Inc

Non-Hodgkin Lymphoma Treatment - Global Forecast 2024-2030

This report can be of interest as well:

Non-Hodgkin Lymphoma Treatment - Global Forecast 2024-2030

Published: January, 2024 | Report code: ASDR-654369